Eric Gorman,Erik Mogalian,Reza Oliyai,Dimitrios Stefanidis,Lauren Wiser,Vahid Zia
申请号：
US15670283
公开号：
US20180021362A1
申请日:
2017.08.07
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Disclosed are pharmaceutical compositions comprising Compound I, having the formula:and an effective amount of sofosbuvir wherein the sofosbuvir is substantially crystalline. Also disclosed are methods of use for the pharmaceutical composition.
